V023-2059 Screening compound: 4-[3-(2-methoxyphenyl)-9-methyl-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]morpholine

V023-2059 Screening compound: 4-[3-(2-methoxyphenyl)-9-methyl-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]morpholine
V023-2059 Screening compound: 4-[3-(2-methoxyphenyl)-9-methyl-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-2059
4-[3-(2-methoxyphenyl)-9-methyl-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-2059

Molecular Formula

C21H21N5O2 (C21 H21 N5 O2)

Compound Name

4-[3-(2-methoxyphenyl)-9-methyl-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]morpholine

IUPAC name

4-[3-(2-methoxyphenyl)-9-methyl-[124]triazolo[43-c]quinazolin-5-yl]morpholine

SMILES

Cc(cc1)cc(c2nnc(-c(cccc3)c3OC)n22)c1nc2N1CCOCC1

InChI

InChI=1S/C21H21N5O2/c1-14-7-8-17-16(13-14)20-24-23-19(15-5-3-4-6-18(15)27-2)26(20)21(22-17)25-9-11-28-12-10-25/h3-8,13H,9-12H2,1-2H3

InChI Key

DTFDMOLHLJZHPT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19922844

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

375.43

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.527

Distribution Coefficient, logD

2.536

Water Solubility, LogSw

-3.70

Polar Surface Area

48.532

Acid Dissociation Constant (pKa)

20.84

Base Dissociation Constant (pKb)

8.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

V023-2059 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V023-2059 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-2059?
Check Price and Availability of V023-2059, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-2059 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-2059
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-2059
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-2059 available by request